Literature DB >> 2305182

Capnophilic and anaerobic bacteremia in neutropenic patients: an oral source.

F Baquero1, J Fernández, F Dronda, A Erice, J Pérez de Oteiza, J A Reguera, M Reig.   

Abstract

The currently accepted empiric antibiotic therapy for bacterial infections in neutropenic patients may not cover the possibility of capnophilic and anaerobic bacteremia. Many of these infections develop in patients with severe mucositis or periodontitis, and the type of organisms recovered also suggests an oral source of infection. We present two cases of bacteremia in neutropenic patients who had been empirically treated with ceftazidime and piperacillin plus amikacin. In the first case a beta-lactamase-producing strain of Capnocytophaga ochracea was isolated; in the second case bacteremia was due to a mixture of Leptotrichia buccalis and Fusobacterium nucleatum. These observations emphasize the necessity for a reevaluation of the possible use of antimicrobial agents active against beta-lactamase-producing capnophilic organisms and anaerobic bacteria during empiric therapy in neutropenic patients with an oral source of infection.

Entities:  

Mesh:

Year:  1990        PMID: 2305182     DOI: 10.1093/clinids/12.supplement_2.s157

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Bacteremia caused by a novel isolate resembling leptotrichia species in a neutropenic patient.

Authors:  J B Patel; J Clarridge; M S Schuster; M Waddington; J Osborne; I Nachamkin
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Chromosome- and plasmid-encoded beta-lactamases in Capnocytophaga spp.

Authors:  Trude Handal; Chantal Giraud-Morin; Dominique A Caugant; Isabelle Madinier; Ingar Olsen; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases.

Authors:  P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun
Journal:  Support Care Cancer       Date:  2003-03-13       Impact factor: 3.603

5.  Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.

Authors:  Judith E Raber-Durlacher; Alexa M G A Laheij; Joel B Epstein; Matthew Epstein; Gerard M Geerligs; Gordon N Wolffe; Nicole M A Blijlevens; J Peter Donnelly
Journal:  Support Care Cancer       Date:  2013-01-04       Impact factor: 3.603

6.  Bacteremia by multidrug-resistant Capnocytophaga sputigena.

Authors:  J L Gomez-Garces; J I Alos; J Sanchez; R Cogollos
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

7.  Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study.

Authors:  Y Ye; G Carlsson; M Barr Agholme; J A L Wilson; A Roos; B Henriques-Normark; L Engstrand; T Modéer; K Pütsep
Journal:  Clin Microbiol Infect       Date:  2013-07-05       Impact factor: 8.067

8.  Mucositis and oral infections secondary to gram negative rods in patients with prolonged neutropenia.

Authors:  Mindy M Sampson; Sowmya Nanjappa; John N Greene
Journal:  IDCases       Date:  2017-07-04

Review 9.  Oral complications in hematopoietic stem cell recipients: the role of inflammation.

Authors:  T M Haverman; J E Raber-Durlacher; W M H Rademacher; S Vokurka; J B Epstein; C Huisman; M D Hazenberg; J J de Soet; J de Lange; F R Rozema
Journal:  Mediators Inflamm       Date:  2014-04-10       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.